The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Avelumab Treatment in Patients With Metastatic Merkel Cell Carcinoma

Celeste Lebb
Published Online: 4:23 PM, Sun September 10, 2017

Celeste Lebbé, MD, from the Hôpital Saint Louis, in Paris, France, discusses avelumab (Bavencio) treatment in chemotherapy-naive patients with distant metastatic Merkel cell carcinoma during the 2017 ESMO Annual Congress.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.